Magalie Joris
Amiens, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.
Journal: Journal of hematology & oncology
Published: April 01, 2026
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Journal: Bone marrow transplantation
Published: March 09, 2026
CPX-351 before allogeneic stem cell transplantation, a real-world French experience.
Journal: Haematologica
Published: March 06, 2026
Nosocomial invasive Aspergillus calidoustus infection in a CAR-T cell-treated patient with concomitant Aspergillus fumigatus respiratory infection.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: December 24, 2025
Life-Threatening Thrombotic Events Revealing Systemic Lupus Erythematosus in a Patient with Chronic Myelomonocytic Leukaemia.
Journal: European journal of case reports in internal medicine
Published: December 15, 2025
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.
Journal: HemaSphere
Published: December 05, 2025
Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysis.
Journal: HemaSphere
Published: July 04, 2025
Last Updated: 09/26/2026